Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target-controlled infusion vs patient-controlled sedation with propofol in ERCP
2009-015564-34Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of propofol in hepatic disease and Hepatobiliary disorders (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: sedation degree. Started Dec 2009; status: completed.
02
Drugs
propofol
03
Conditions
hepatic diseaseHepatobiliary disorders
Beyond the preview
Go deeper on 2009-015564-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015564-34.